Home example 2 - Pharmamarketeer

overig

8 psychologische onderzoeken & de inzichten voor je marketingteam

De economie gaat uit van een rationeel denkende consument. Maar de laatste decennia hebben ons voldoende inzichten gegeven dat consumenten lang niet altijd rationeel handelen.

Frankwatching.nl

2 x gelezen

overig

Proton beam therapy finally arrives in UK

28 years after the US first pioneered proton beam therapy at Loma Linda University Medical Center, the UK now has its own centre that will be able to provide this type of treatment to patients.

Pharmafile

2 x gelezen

onderzoek

Large study finds no link between blood pressure medication and cancer

Blood pressure medication There is no evidence that blood pressure lowering drugs increase the risk of cancer, according to the most extensive study conducted on the topic. The late breaking research is presented today...

EurekAlert

2 x gelezen

wet- en regelgeving

FDA approves new drug for treatment of lung disease caused by Mycobacterium avium complex

The U.S. Food and Drug Administration today approved a new drug, Arikayce, for the treatment of lung disease caused by a group of bacteria, Mycobacterium avium complex in a limited population of patients with the...

News-Medical.Net

2 x gelezen

farma-industrie

Servier on trial for weight-loss pill that led to 2,000 deaths

A trial on one of France’s largest ever healthcare scandals has begun after a weight loss pill was believed to have killed up to 2,000 people, leaving many more injured for life. Pharmaceutical giant Servier is one of...

InPharm.com

2 x gelezen

onderzoek

AZ’s Farxiga shows strength in largest ever SGLT2 inhibitor cardiovascular outcomes study

AstraZeneca has revealed new data for its sodium-glucose co-transporter 2 (SGLT2) inhibitor Farxiga (dapagliflozin) at the American Heart Association (AHA) Scientific Sessions 2018 in Chicago, showing that the drug...

InPharm.com

2 x gelezen

wet- en regelgeving

FDA approves MSD’s combo therapy Recarbrio for urinary tract and intra-abdominal infections

MSD has announced the approval from the FDA of its combination therapy Recarbrio (imipenem, cilastatin and relebactam) in the treatment of adult patients with complicated urinary tract infections (cUTI) and complicated...

InPharm.com

2 x gelezen

wet- en regelgeving

Nieuwe vergunning voor sotagliflozine

Sotagliflozine (Zynquista) kreeg een positief advies voor een nieuwe handelsvergunning van de Committee for Medicinal Products for Human Use (CHMP). Het middel is bestemd als toevoeging op insulinetherapie voor bepaalde...

Pharmaceutisch Weekblad

2 x gelezen

onderzoek

Cancer drugs reprogram genes in breast tumors to prevent endocrine resistance, finds study

Treating breast tumors with two cancer drugs simultaneously may prevent endocrine resistance by attacking the disease along two separate gene pathways, scientists at the University of Illinois found in a new study.

News-Medical.Net

2 x gelezen

marketing

MIE ’19: focus op insights en groei

Ruim 2300 (digital) marketeers, growth hackers, strategen en insights professionals bezochten op 6 en 7 februari het MIE, het grootste Marketing Insights Event van Nederland. Opvallend in de presentaties van dit jaar...

MarketingTribune

2 x gelezen

Latest articles

8 psychologische onderzoeken & de inzichten voor je marketingteam

Proton beam therapy finally arrives in UK

Large study finds no link between blood pressure medication and cancer

FDA approves new drug for treatment of lung disease caused by Mycobacterium avium complex

Servier on trial for weight-loss pill that led to 2,000 deaths

AZ’s Farxiga shows strength in largest ever SGLT2 inhibitor cardiovascular outcomes study

FDA approves MSD’s combo therapy Recarbrio for urinary tract and intra-abdominal infections

Nieuwe vergunning voor sotagliflozine

Cancer drugs reprogram genes in breast tumors to prevent endocrine resistance, finds study

MIE ’19: focus op insights en groei

Wekelijkse highlights per e-mail

Algemene informatie